Proteomic signature of endothelial dysfunction identified in the serum of acute ischemic stroke patients by the iTRAQ-based LC-MS approach

Journal of Proteome Research

Volumn 14, Issue 6, 2015, Pages 2466-2479

  Sharma, Rakesh ^a,b,c   Gowda, Harsha ^d   Chavan, Sandip ^d,e   Advani, Jayshree ^d,e   Kelkar, Dhanashree ^d   Kumar, G S Sameer ^d   Bhattacharjee, Mitali ^d   Chaerkady, Raghothama ^d,e   Prasad, T S Keshava ^d,e   Pandey, Akhilesh ^d,f   Nagaraja, Dindagur ^g   Christopher, Rita ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c CITY UNIVERSITY OF HONG KONG   (Hong Kong)

^d INSTITUTE OF BIOINFORMATICS   (India)

^e MANIPAL UNIVERSITY   (India)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g Dharwad Institute of Mental Health and Neurosciences   (India)

Author keywords

diagnostic marker; hemostasis; high density lipoprotein (HDL); inflammation; ischemic stroke; low density lipoprotein (LDL); LTQ Orbitrap mass spectrometer; thrombus

Indexed keywords

BIOLOGICAL MARKER; POSTSYNAPTIC DENSITY PROTEIN 95; PROTEIN; PSORIASIN; REAGENT; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; ANGIOGENESIS; ARTICLE; BLOOD SAMPLING; BRAIN ISCHEMIA; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOMEOSTASIS; HUMAN; HUMAN CELL; INFLAMMATION; LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY MASS SPECTROMETRY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETER; MASS SPECTROMETRY; MIDDLE AGED; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEOMICS; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SERUM; STROKE PATIENT; TANDEM MASS SPECTROMETRY; BLOOD; CEREBROVASCULAR ACCIDENT; METABOLISM; PATHOPHYSIOLOGY; PROCEDURES; VASCULAR ENDOTHELIUM;

ADULT; BIOMARKERS; BRAIN ISCHEMIA; CHROMATOGRAPHY, LIQUID; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEOMICS; STROKE; TANDEM MASS SPECTROMETRY;

EID: 84930608335     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr501324n     Document Type: Article

References (78)

1. Hacke, W.; Furlan, A. J.; Al-Rawi, Y.; Davalos, A.; Fiebach, J. B.; Gruber, F.; Kaste, M.; Lipka, L. J.; Pedraza, S.; Ringleb, P. A.; Rowley, H. A.; Schneider, D.; Schwamm, L. H.; Leal, J. S.; Sohngen, M.; Teal, P. A.; Wilhelm-Ogunbiyi, K.; Wintermark, M.; Warach, S. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study Lancet Neurol. 2009, 8 (2) 141-50
2. Levy, D. E.; del Zoppo, G. J.; Demaerschalk, B. M.; Demchuk, A. M.; Diener, H. C.; Howard, G.; Kaste, M.; Pancioli, A. M.; Ringelstein, E. B.; Spatareanu, C.; Wasiewski, W. W. Ancrod in acute ischemic stroke: results of 500 subjects beginning treatment within 6 h of stroke onset in the ancrod stroke program Stroke 2009, 40 (12) 3796-803
3. Kim, M. H.; Kang, S. Y.; Kim, M. C.; Lee, W. I. Plasma biomarkers in the diagnosis of acute ischemic stroke Ann. Clin. Lab. Sci. 2010, 40 (4) 336-41
4. Apweiler, R.; Aslanidis, C.; Deufel, T.; Gerstner, A.; Hansen, J.; Hochstrasser, D.; Kellner, R.; Kubicek, M.; Lottspeich, F.; Maser, E.; Mewes, H. W.; Meyer, H. E.; Mullner, S.; Mutter, W.; Neumaier, M.; Nollau, P.; Nothwang, H. G.; Ponten, F.; Radbruch, A.; Reinert, K.; Rothe, G.; Stockinger, H.; Tarnok, A.; Taussig, M. J.; Thiel, A.; Thiery, J.; Ueffing, M.; Valet, G.; Vandekerckhove, J.; Verhuven, W.; Wagener, C.; Wagner, O.; Schmitz, G. Approaching clinical proteomics: current state and future fields of application in fluid proteomics Clin. Chem. Lab. Med. 2009, 47 (6) 724-44
5. Chambers, G.; Lawrie, L.; Cash, P.; Murray, G. I. Proteomics: a new approach to the study of disease J. Pathol. 2000, 192 (3) 280-8
6. Hu, S.; Loo, J. A.; Wong, D. T. Human body fluid proteome analysis Proteomics 2006, 6 (23) 6326-53
7. Hu, S.; Loo, J. A.; Wong, D. T. Human saliva proteome analysis and disease biomarker discovery Expert Rev. Proteomics 2007, 4 (4) 531-8
8. Hanash, S.; Schliekelman, M. Proteomic profiling of the tumor microenvironment: recent insights and the search for biomarkers Genome Med. 2014, 6 (2) 12
9. Prentice, R. L.; Zhao, S.; Johnson, M.; Aragaki, A.; Hsia, J.; Jackson, R. D.; Rossouw, J. E.; Manson, J. E.; Hanash, S. M. Proteomic risk markers for coronary heart disease and stroke: validation and mediation of randomized trial hormone therapy effects on these diseases Genome Med. 2013, 5 (12) 112
10. Taguchi, A.; Hanash, S. M. Unleashing the power of proteomics to develop blood-based cancer markers Clin. Chem. 2013, 59 (1) 119-26
11. Huttenhain, R.; Soste, M.; Selevsek, N.; Rost, H.; Sethi, A.; Carapito, C.; Farrah, T.; Deutsch, E. W.; Kusebauch, U.; Moritz, R. L.; Nimeus-Malmstrom, E.; Rinner, O.; Aebersold, R. Reproducible quantification of cancer-associated proteins in body fluids using targeted proteomics Sci. Transl. Med. 2012, 4 (142) 142ra94
12. Venugopal, A.; Chaerkady, R.; Pandey, A. Application of mass spectrometry-based proteomics for biomarker discovery in neurological disorders Ann. Indian Acad. Neurol. 2009, 12 (1) 3-11
13. Hatfield, R. H.; McKernan, R. M. CSF neuron-specific enolase as a quantitative marker of neuronal damage in a rat stroke model Brain Res. 1992, 577 (2) 249-52
14. Altug, M. E.; Serarslan, Y.; Bal, R.; Kontas, T.; Ekici, F.; Melek, I. M.; Aslan, H.; Duman, T. Caffeic acid phenethyl ester protects rabbit brains against permanent focal ischemia by antioxidant action: a biochemical and planimetric study Brain Res. 2008, 1201, 135-42
15. Park, K. P.; Rosell, A.; Foerch, C.; Xing, C.; Kim, W. J.; Lee, S.; Opdenakker, G.; Furie, K. L.; Lo, E. H. Plasma and brain matrix metalloproteinase-9 after acute focal cerebral ischemia in rats Stroke 2009, 40 (8) 2836-42
16. Lee, W. C.; Wong, H. Y.; Chai, Y. Y.; Shi, C. W.; Amino, N.; Kikuchi, S.; Huang, S. H. Lipid peroxidation dysregulation in ischemic stroke: plasma 4-HNE as a potential biomarker? Biochem. Biophys. Res. Commun. 2012, 425 (4) 842-7
17. Chen, R.; Vendrell, I.; Chen, C. P.; Cash, D.; OToole, K. G.; Williams, S. A.; Jones, C.; Preston, J. E.; Wheeler, J. X. Proteomic analysis of rat plasma following transient focal cerebral ischemia Biomark. Med. 2011, 5 (6) 837-46
18. Gautam, P.; Nair, S. C.; Gupta, M. K.; Sharma, R.; Polisetty, R. V.; Uppin, M. S.; Sundaram, C.; Puligopu, A. K.; Ankathi, P.; Purohit, A. K.; Chandak, G. R.; Harsha, H. C.; Sirdeshmukh, R. Proteins with altered levels in plasma from glioblastoma patients as revealed by iTRAQ-based quantitative proteomic analysis PLoS One 2012, 7 (9) e46153
19. Polisetty, R. V.; Gautam, P.; Sharma, R.; Harsha, H. C.; Nair, S. C.; Gupta, M. K.; Uppin, M. S.; Challa, S.; Puligopu, A. K.; Ankathi, P.; Purohit, A. K.; Chandak, G. R.; Pandey, A.; Sirdeshmukh, R. LC-MS/MS analysis of differentially expressed glioblastoma membrane proteome reveals altered calcium signaling and other protein groups of regulatory functions Mol. Cell. Proteomics 2012, 11 (6) M111.013565
20. Chen, D.; Shah, A.; Nguyen, H.; Loo, D.; Inder, K. L.; Hill, M. M. Online Quantitative Proteomics p-Value Calculator for Permutation-Based Statistical Testing of Peptide Ratios J. Proteome Res. 2014, 13 (9) 4184-91
21. Goel, R.; Muthusamy, B.; Pandey, A.; Prasad, T. S. Human protein reference database and human proteinpedia as discovery resources for molecular biotechnology Mol. Biotechnol. 2011, 48 (1) 87-95
22. Schisterman, E. F.; Perkins, N. J.; Liu, A.; Bondell, H. Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples Epidemiology 2005, 16 (1) 73-81
23. Nanjappa, V.; Thomas, J. K.; Marimuthu, A.; Muthusamy, B.; Radhakrishnan, A.; Sharma, R.; Ahmad Khan, A.; Balakrishnan, L.; Sahasrabuddhe, N. A.; Kumar, S.; Jhaveri, B. N.; Sheth, K. V.; Kumar Khatana, R.; Shaw, P. G.; Srikanth, S. M.; Mathur, P. P.; Shankar, S.; Nagaraja, D.; Christopher, R.; Mathivanan, S.; Raju, R.; Sirdeshmukh, R.; Chatterjee, A.; Simpson, R. J.; Harsha, H. C.; Pandey, A.; Prasad, T. S. Plasma Proteome Database as a resource for proteomics research: 2014 update Nucleic Acids Res. 2014, 42 (Database issue) D959-65
24. Nielsen, H.; Brunak, S.; von Heijne, G. Machine learning approaches for the prediction of signal peptides and other protein sorting signals Protein Eng. 1999, 12 (1) 3-9
25. Valentijn, K. M.; Eikenboom, J. Weibel-Palade bodies: a window to von Willebrand disease J. Thromb. Haemostasis 2013, 11 (4) 581-92
26. Reynolds, M. A.; Kirchick, H. J.; Dahlen, J. R.; Anderberg, J. M.; McPherson, P. H.; Nakamura, K. K.; Laskowitz, D. T.; Valkirs, G. E.; Buechler, K. F. Early biomarkers of stroke Clin. Chem. 2003, 49 (10) 1733-9
27. Lynch, J. R.; Blessing, R.; White, W. D.; Grocott, H. P.; Newman, M. F.; Laskowitz, D. T. Novel diagnostic test for acute stroke Stroke 2004, 35 (1) 57-63
28. Laskowitz, D. T.; Blessing, R.; Floyd, J.; White, W. D.; Lynch, J. R. Panel of biomarkers predicts stroke Ann. N. Y. Acad. Sci. 2005, 1053, 30
29. Bongers, T. N.; de Maat, M. P.; van Goor, M. L.; Bhagwanbali, V.; van Vliet, H. H.; Gomez Garcia, E. B.; Dippel, D. W.; Leebeek, F. W. High von Willebrand factor levels increase the risk of first ischemic stroke: influence of ADAMTS13, inflammation, and genetic variability Stroke 2006, 37 (11) 2672-7
30. Andersson, H. M.; Siegerink, B.; Luken, B. M.; Crawley, J. T.; Algra, A.; Lane, D. A.; Rosendaal, F. R. High VWF, low ADAMTS13, and oral contraceptives increase the risk of ischemic stroke and myocardial infarction in young women Blood 2012, 119 (6) 1555-60
31. Pendu, R.; Terraube, V.; Christophe, O. D.; Gahmberg, C. G.; de Groot, P. G.; Lenting, P. J.; Denis, C. V. P-selectin glycoprotein ligand 1 and beta2-integrins cooperate in the adhesion of leukocytes to von Willebrand factor Blood 2006, 108 (12) 3746-52
32. Bernardo, A.; Ball, C.; Nolasco, L.; Choi, H.; Moake, J. L.; Dong, J. F. Platelets adhered to endothelial cell-bound ultra-large von Willebrand factor strings support leukocyte tethering and rolling under high shear stress J. Thromb. Haemostasis 2005, 3 (3) 562-70
33. Petri, B.; Broermann, A.; Li, H.; Khandoga, A. G.; Zarbock, A.; Krombach, F.; Goerge, T.; Schneider, S. W.; Jones, C.; Nieswandt, B.; Wild, M. K.; Vestweber, D. von Willebrand factor promotes leukocyte extravasation Blood 2010, 116 (22) 4712-9
34. Stenina, O. I.; Desai, S. Y.; Krukovets, I.; Kight, K.; Janigro, D.; Topol, E. J.; Plow, E. F. Thrombospondin-4 and its variants: expression and differential effects on endothelial cells Circulation 2003, 108 (12) 1514-9
35. Mustonen, E.; Aro, J.; Puhakka, J.; Ilves, M.; Soini, Y.; Leskinen, H.; Ruskoaho, H.; Rysa, J. Thrombospondin-4 expression is rapidly upregulated by cardiac overload Biochem. Biophys. Res. Commun. 2008, 373 (2) 186-91
36. Tan, F. L.; Moravec, C. S.; Li, J.; Apperson-Hansen, C.; McCarthy, P. M.; Young, J. B.; Bond, M. The gene expression fingerprint of human heart failure Proc. Natl. Acad. Sci. U. S. A. 2002, 99 (17) 11387-92
37. Gabrielsen, A.; Lawler, P. R.; Yongzhong, W.; Steinbruchel, D.; Blagoja, D.; Paulsson-Berne, G.; Kastrup, J.; Hansson, G. K. Gene expression signals involved in ischemic injury, extracellular matrix composition and fibrosis defined by global mRNA profiling of the human left ventricular myocardium J. Mol. Cell. Cardiol. 2007, 42 (4) 870-83
38. Frolova, E. G.; Pluskota, E.; Krukovets, I.; Burke, T.; Drumm, C.; Smith, J. D.; Blech, L.; Febbraio, M.; Bornstein, P.; Plow, E. F.; Stenina, O. I. Thrombospondin-4 regulates vascular inflammation and atherogenesis Circ. Res. 2010, 107 (11) 1313-25
39. Simundic, A. M.; Basic, V.; Topic, E.; Demarin, V.; Vrkic, N.; Kunovic, B.; Stefanovic, M.; Begonja, A. Soluble adhesion molecules in acute ischemic stroke Clin. Invest. Med. 2004, 27 (2) 86-92
40. Bossowska, A.; Kiersnowska-Rogowska, B.; Bossowski, A.; Galar, B.; Sowinski, P. Assessment of serum levels of adhesion molecules (sICAM-1, sVCAM-1, sE-selectin) in stable and unstable angina and acute myocardial infarction Przegl. Lek. 2003, 60 (7) 445-50
41. Arenillas, J. F.; Alvarez-Sabin, J.; Molina, C. A.; Chacon, P.; Montaner, J.; Rovira, A.; Ibarra, B.; Quintana, M. C-reactive protein predicts further ischemic events in first-ever transient ischemic attack or stroke patients with intracranial large-artery occlusive disease Stroke 2003, 34 (10) 2463-8
42. Rost, N. S.; Wolf, P. A.; Kase, C. S.; Kelly-Hayes, M.; Silbershatz, H.; Massaro, J. M.; DAgostino, R. B.; Franzblau, C.; Wilson, P. W. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study Stroke 2001, 32 (11) 2575-9
43. Seo, W. K.; Seok, H. Y.; Kim, J. H.; Park, M. H.; Yu, S. W.; Oh, K.; Koh, S. B.; Park, K. W. C-reactive protein is a predictor of early neurologic deterioration in acute ischemic stroke J. Stroke Cerebrovasc. Dis. 2012, 21 (3) 181-6
44. Audebert, H. J.; Rott, M. M.; Eck, T.; Haberl, R. L. Systemic inflammatory response depends on initial stroke severity but is attenuated by successful thrombolysis Stroke 2004, 35 (9) 2128-33
45. Daugherty, A.; Dunn, J. L.; Rateri, D. L.; Heinecke, J. W. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions J. Clin. Invest. 1994, 94 (1) 437-44
46. Malle, E.; Marsche, G.; Arnhold, J.; Davies, M. J. Modification of low-density lipoprotein by myeloperoxidase-derived oxidants and reagent hypochlorous acid Biochim. Biophys. Acta 2006, 1761 (4) 392-415
47. Pawlus, J.; Holub, M.; Kozuch, M.; Dabrowska, M.; Dobrzycki, S. Serum myeloperoxidase levels and platelet activation parameters as diagnostic and prognostic markers in the course of coronary disease Int. J. Lab Hematol. 2010, 32 (3) 320-8
48. Burdess, A.; Michelsen, A. E.; Brosstad, F.; Fox, K. A.; Newby, D. E.; Nimmo, A. F. Platelet activation in patients with peripheral vascular disease: reproducibility and comparability of platelet markers Thromb. Res. 2012, 129 (1) 50-5
49. Zhan, Q.; Yuan, M.; Wang, X. H.; Duan, X. M.; Yang, Q. D.; Xia, J. Association of lipopolysaccharide-binding protein gene polymorphisms with cerebral infarction in a Chinese population J. Thromb. Thrombolysis 2012, 34 (2) 260-8
50. Lepper, P. M.; Schumann, C.; Triantafilou, K.; Rasche, F. M.; Schuster, T.; Frank, H.; Schneider, E. M.; Triantafilou, M.; von Eynatten, M. Association of lipopolysaccharide-binding protein and coronary artery disease in men J. Am. Coll. Cardiol. 2007, 50 (1) 25-31
51. Meek, R. L.; Urieli-Shoval, S.; Benditt, E. P. Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function Proc. Natl. Acad. Sci. U. S. A. 1994, 91 (8) 3186-90
52. Brea, D.; Sobrino, T.; Blanco, M.; Fraga, M.; Agulla, J.; Rodriguez-Yanez, M.; Rodriguez-Gonzalez, R.; Perez de la Ossa, N.; Leira, R.; Forteza, J.; Davalos, A.; Castillo, J. Usefulness of haptoglobin and serum amyloid A proteins as biomarkers for atherothrombotic ischemic stroke diagnosis confirmation Atherosclerosis 2009, 205 (2) 561-7
53. Ahima, R. S.; Osei, S. Y. Adipokines in obesity Front. Horm. Res. 2008, 36, 182-97
54. Steffens, S.; Mach, F. Adiponectin and adaptive immunity: linking the bridge from obesity to atherogenesis Circ. Res. 2008, 102 (2) 140-2
55. Nishimura, M.; Izumiya, Y.; Higuchi, A.; Shibata, R.; Qiu, J.; Kudo, C.; Shin, H. K.; Moskowitz, M. A.; Ouchi, N. Adiponectin prevents cerebral ischemic injury through endothelial nitric oxide synthase dependent mechanisms Circulation 2008, 117 (2) 216-23
56. Ikeda, Y.; Aihara, K.; Yoshida, S.; Iwase, T.; Tajima, S.; Izawa-Ishizawa, Y.; Kihira, Y.; Ishizawa, K.; Tomita, S.; Tsuchiya, K.; Sata, M.; Akaike, M.; Kato, S.; Matsumoto, T.; Tamaki, T. Heparin cofactor II, a serine protease inhibitor, promotes angiogenesis via activation of the AMP-activated protein kinase-endothelial nitric-oxide synthase signaling pathway J. Biol. Chem. 2012, 287 (41) 34256-63
57. Wheatcroft, S. B.; Kearney, M. T.; Shah, A. M.; Grieve, D. J.; Williams, I. L.; Miell, J. P.; Crossey, P. A. Vascular endothelial function and blood pressure homeostasis in mice overexpressing IGF binding protein-1 Diabetes 2003, 52 (8) 2075-82
58. Cook, D. J.; Teves, L.; Tymianski, M. Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain Nature 2012, 483 (7388) 213-7
59. Wolf, R.; Howard, O. M.; Dong, H. F.; Voscopoulos, C.; Boeshans, K.; Winston, J.; Divi, R.; Gunsior, M.; Goldsmith, P.; Ahvazi, B.; Chavakis, T.; Oppenheim, J. J.; Yuspa, S. H. Chemotactic activity of S100A7 (Psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15 J. Immunol. 2008, 181 (2) 1499-506
60. Lee, K. C.; Eckert, R. L. S100A7 (Psoriasin) - mechanism of antibacterial action in wounds J. Invest. Dermatol. 2007, 127 (4) 945-57
61. Jansen, S.; Podschun, R.; Leib, S. L.; Grotzinger, J.; Oestern, S.; Michalek, M.; Pufe, T.; Brandenburg, L. O. Expression and function of psoriasin (S100A7) and koebnerisin (S100A15) in the brain Infect. Immun. 2013, 81 (5) 1788-97
62. Qin, W.; Ho, L.; Wang, J.; Peskind, E.; Pasinetti, G. M. S100A7, a novel Alzheimers disease biomarker with non-amyloidogenic alpha-secretase activity acts via selective promotion of ADAM-10 PLoS One 2009, 4 (1) e4183
63. Shubbar, E.; Vegfors, J.; Carlstrom, M.; Petersson, S.; Enerback, C. Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation Breast Cancer Res. Treat. 2012, 134 (1) 71-80
64. Chen, J.; Zhang, Z. G.; Li, Y.; Wang, L.; Xu, Y. X.; Gautam, S. C.; Lu, M.; Zhu, Z.; Chopp, M. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats Circ. Res. 2003, 92 (6) 692-9
65. Slevin, M.; Krupinski, J.; Slowik, A.; Kumar, P.; Szczudlik, A.; Gaffney, J. Serial measurement of vascular endothelial growth factor and transforming growth factor-beta1 in serum of patients with acute ischemic stroke Stroke 2000, 31 (8) 1863-70
66. Le, H. T.; Hirko, A. C.; Thinschmidt, J. S.; Grant, M.; Li, Z.; Peris, J.; King, M. A.; Hughes, J. A.; Song, S. The protective effects of plasma gelsolin on stroke outcome in rats Exp. Transl. Stroke Med. 2011, 3 (1) 13
67. Lind, S. E.; Smith, D. B.; Janmey, P. A.; Stossel, T. P. Depression of gelsolin levels and detection of gelsolin-actin complexes in plasma of patients with acute lung injury Am. Rev. Respir. Dis. 1988, 138 (2) 429-34
68. Endres, M.; Fink, K.; Zhu, J.; Stagliano, N. E.; Bondada, V.; Geddes, J. W.; Azuma, T.; Mattson, M. P.; Kwiatkowski, D. J.; Moskowitz, M. A. Neuroprotective effects of gelsolin during murine stroke J. Clin. Invest. 1999, 103 (3) 347-54
69. Lu, B.; Zhang, Q.; Wang, H.; Wang, Y.; Nakayama, M.; Ren, D. Extracellular calcium controls background current and neuronal excitability via an UNC79-UNC80-NALCN cation channel complex Neuron 2010, 68 (3) 488-99
70. Lear, B. C.; Darrah, E. J.; Aldrich, B. T.; Gebre, S.; Scott, R. L.; Nash, H. A.; Allada, R. UNC79 and UNC80, putative auxiliary subunits of the NARROW ABDOMEN ion channel, are indispensable for robust circadian locomotor rhythms in Drosophila PLoS One 2013, 8 (11) e78147
71. Harmon, E. Y.; Fronhofer, V., 3rd; Keller, R. S.; Feustel, P. J.; Zhu, X.; Xu, H.; Avram, D.; Jones, D. M.; Nagarajan, S.; Lennartz, M. R. Anti-inflammatory immune skewing is atheroprotective: Apoe-/-FcgammaRIIb-/- mice develop fibrous carotid plaques J. Am. Heart Assoc. 2014, 3 (6) e001232
72. Zhai, Y.; Yamashita, T.; Kurata, T.; Fukui, Y.; Sato, K.; Kono, S.; Liu, W.; Omote, Y.; Hishikawa, N.; Deguchi, K.; Abe, K. Strong reduction of low-density lipoprotein receptor/apolipoprotein E expressions by telmisartan in cerebral cortex and hippocampus of stroke resistant spontaneously hypertensive rats J. Stroke Cerebrovasc. Dis. 2014, 23 (9) 2350-61
73. Falcone, G. J.; Radmanesh, F.; Brouwers, H. B.; Battey, T. W.; Devan, W. J.; Valant, V.; Raffeld, M. R.; Chitsike, L. P.; Ayres, A. M.; Schwab, K.; Goldstein, J. N.; Viswanathan, A.; Greenberg, S. M.; Selim, M.; Meschia, J. F.; Brown, D. L.; Worrall, B. B.; Silliman, S. L.; Tirschwell, D. L.; Flaherty, M. L.; Martini, S. R.; Deka, R.; Biffi, A.; Kraft, P.; Woo, D.; Rosand, J.; Anderson, C. D. APOE epsilon variants increase risk of warfarin-related intracerebral hemorrhage Neurology 2014, 83 (13) 1139-46
74. Blazejewska-Hyzorek, B.; Gromadzka, G.; Skowronska, M.; Czlonkowska, A. APOE 2 allele is an independent risk factor for vulnerable carotid plaque in ischemic stroke patients Neurol. Res. 2014, 36 (11) 950-4
75. Alzate, O.; Osorio, C.; DeKroon, R. M.; Corcimaru, A.; Gunawardena, H. P. Differentially charged isoforms of apolipoprotein E from human blood are potential biomarkers of Alzheimers disease Alzheimers Res. Ther. 2014, 6 (4) 43
76. Han, S. H.; Kim, J. S.; Lee, Y.; Choi, H.; Kim, J. W.; Na, D. L.; Yang, E. G.; Yu, M. H.; Hwang, D.; Lee, C.; Mook-Jung, I. Both targeted mass spectrometry and flow sorting analysis methods detected the decreased serum apolipoprotein E level in Alzheimers disease patients Mol. Cell. Proteomics 2014, 13 (2) 407-19
77. Lad, S. P.; Hegen, H.; Gupta, G.; Deisenhammer, F.; Steinberg, G. K. Proteomic biomarker discovery in cerebrospinal fluid for cerebral vasospasm following subarachnoid hemorrhage J. Stroke Cerebrovasc. Dis. 2012, 21 (1) 30-41
78. Kim, Y. J.; Lee, S. M.; Cho, H. J.; Do, H. J.; Hong, C. H.; Shin, M. J.; Kim, Y. S. Plasma levels of apolipoprotein E and risk of intracranial artery stenosis in acute ischemic stroke patients Ann. Nutr. Metab. 2013, 62 (1) 26-31